Last quarter (Q ), 180 Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, 180 Life Sciences's net income was $-10.00M. See 180 Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expense	$ 32.57M	$ 17.90M	$ 15.64M	$ 5.65M	$ 20.89M
Operating Income	$ -8.23M	$ -17.90M	$ -15.64M	$ -5.65M	$ -20.89M
Net Non Operating Interest Income Expense	$ -40.84K	$ -36.42K	$ -799.73K	$ -1.09M	$ -181.41K
Other Income Expense	$ 8.02M	$ -11.78M	$ 4.83M	$ -4.17M	$ -4.33M
Pretax Income	$ -43.74M	$ -39.67M	$ -20.35M	$ -10.90M	$ -25.40M
Tax Provision	$ -3.29M	$ -942.75K	$ -23.20K	$ -20.43K	$ -9.50K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -31.01M	$ -38.73M	$ -20.32M	$ -12.01M	$ -25.39M
Basic EPS	$ -23.23	$ -20.38	$ -12.96	$ -0.66	$ -2.30
Diluted EPS	$ -21.40	$ -18.55	$ -12.96	$ -0.66	$ -2.30
Basic Average Shares	$ 18.83M	$ 1.90M	$ 1.57M	$ 18.15M	$ 11.04M
Diluted Average Shares	$ 16.93M	$ 1.90M	$ 1.57M	$ 18.15M	$ 11.04M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 32.57M	$ 17.90M	$ 15.64M	$ 5.65M	$ 20.89M
Net Income From Continuing And Discontinued Operation	$ -31.28M	$ -38.73M	$ -20.32M	$ -10.88M	$ -25.39M
Normalized Income	$ -8.80M	$ 29.95M	-	$ -6.46M	$ -20.81M
Interest Expense	-	-	-	$ 1.09M	$ 185.14K
EBIT	$ -43.77M	$ -39.63M	$ -20.37M	$ -9.82M	$ -25.22M
EBITDA	$ -42.01M	$ -39.52M	$ -20.26M	$ -9.69M	$ -25.15M

Currency in USD

180 Life Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing